Shilpa Medicare's Unit VI clears USFDA inspection
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - Oral Dissolving Films and Transdermal Systems.
The Unit is already approved by EMA, Europe; MHRA, UK; SFDA, Saudi and TGA, Australia.
This Unit is currently supplying Oral Film products to US and other markets. Transdermal products have been filed in the European market.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content